IP Verse

Lateral Flow Immunoassays For The Detection Of Antibodies Against Biological Drugs - EP3092497

The patent EP3092497 was granted to Progenika Biopharma on Mar 15, 2017. The application was originally filed on Jul 27, 2015 under application number EP15767581A. The patent is currently recorded with a legal status of "Revoked".

EP3092497

PROGENIKA BIOPHARMA
Application Number
EP15767581A
Filing Date
Jul 27, 2015
Status
Revoked
Sep 23, 2022
Grant Date
Mar 15, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BUHLMANN LABORATORIESDec 15, 2017STOLMAR & PARTNERADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONWO2006119160
OPPOSITIONWO2011005357
OPPOSITIONWO2011135024

Non-Patent Literature (NPL) Citations (35) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BENDTZEN, K ET AL., ARTHRITIS RHEUM, (2011), vol. 63, pages 867 - 870-
DESCRIPTION- CORSTJENS, PL. ET AL., ANAL BIOANAL CHEM, (2013), vol. 405, pages 7367 - 7375-
DESCRIPTION- DE VRIES, MK. ET AL., ANN RHEUM DIS, (2007), vol. 66, pages 1252 - 1254-
DESCRIPTION- FURST, DE. ET AL., ARTHRITIS CARE RES, (2011), vol. 63, pages 856 - 864-
DESCRIPTION- GOROVITS, B., AAPS J, (2009), vol. 11, pages 133 - 138-
DESCRIPTION- HART, MH. ET AL., J IMMUNOL METHODS, (2011), vol. 372, pages 196 - 203-
DESCRIPTION- JAMNITSKI, A. ET AL., ANN RHEUM DIS, (2011), vol. 70, pages 284 - 288-
DESCRIPTION- JEMEC, GB., BR J DERMATOL, (2013), vol. 168, page 233-
DESCRIPTION- KOPYLOV, U. ET AL., ALIMENTARY PHARMACOLOGY & THERAPEUTICS, (2011), vol. 33, pages 349 - 357-
DESCRIPTION- KORSWAGEN, LA. ET AL., ARTHRITIS RHEUM, (2011), vol. 63, pages 877 - 883-
DESCRIPTION- KRIECKAERT, CL. ET AL., ARTHRITIS RES THER, (2010), vol. 12, page 217-
DESCRIPTION- LALLEMAND, C. ET AL., J IMMUNOL METHODS, (2011), vol. 373, pages 229 - 239-
DESCRIPTION- PAN, J. ET AL., JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, (2011), vol. 63, pages 150 - 159-
DESCRIPTION- PAN, J., JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, (2011), vol. 63, pages 150 - 159-
DESCRIPTION- PASCUAL-SALCEDO, D. ET AL., RHEUMATOLOGY, (2011), vol. 50, pages 1445 - 1452-
DESCRIPTION- PASCUAL-SALCEDO, D., RHEUMATOLOGY, (2011), vol. 50, pages 1445 - 1452-
DESCRIPTION- PLASENCIA, C. ET AL., ANN RHEUM DIS, (2012), vol. 71, pages 1955 - 1960-
DESCRIPTION- PLASENCIA., C. ET AL., ANN RHEUM DIS, (2012), vol. 71, pages 1955 - 1960-
DESCRIPTION- VAN SCHOUWENBURG, PA. ET AL., ANN RHEUM DIS, (2012), vol. 72, pages 104 - 109-
DESCRIPTION- VINCENT, FB. ET AL., ANN RHEUM DIS, (2013), vol. 72, pages 165 - 178-
DESCRIPTION- WANG, SL. ET AL., J IMMUNOL METHODS, (2012), vol. 382, pages 177 - 188-
INTERNATIONAL-SEARCH-REPORT- Abd Serotec, "Effective Tools for Drug Monitoring Assays", Richmond CA USA, (20070808), pages 1 - 2, URL: https://static.abdserotec.com/2014/anti-ids/effective-tools-for-drug-monitoring-assays-08jul14.pdf, (20150609), XP055194505 [T] * page 1, figure 1B *-
INTERNATIONAL-SEARCH-REPORT- Timothy Nelson & Dorothy L. Smith, "BIOLOGICAL DRUGS: DRUGS OF THE FUTURE", Consumer Health Information, McLean, VA, USA, (20080101), pages 1 - 2, URL: http://www.consumer-health.com/services/biological_drugs.php, (20150609), XP055194456 [A] 1-15 * page 1, section "How do biological drugs work?", line 1 *-
INTERNATIONAL-SEARCH-REPORT- P. L. A. M. CORSTJENS ET AL, "A rapid assay for on-site monitoring of infliximab trough levels: a feasibility study", ANALYTICAL AND BIOANALYTICAL CHEMISTRY, New York NY USA, (20130709), vol. 405, no. 23, doi:10.1007/s00216-013-7154-0, ISSN 1618-2642, pages 7367 - 7375, XP055194628 [AD] 1-15 * page 7369, figure 1 *
INTERNATIONAL-SEARCH-REPORT- M. TORNETTA ET AL, "Isolation of human anti-idiotypic antibodies by phage display for clinical immune response assays", JOURNAL OF IMMUNOLOGICAL METHODS, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, (20071030), vol. 328, no. 1-2, doi:10.1016/J.JIM.2007.08.008, ISSN 0022-1759, pages 34 - 44, XP022322495 [Y] 1-15 * page 41, figure 6;; figure 6 *
INTERNATIONAL-SEARCH-REPORT- WANG H ET AL, "A rapid immunochromatographic test strip for detecting rabies virus antibody", JOURNAL OF VIROLOGICAL METHODS, ELSEVIER BV, Amsterdam, vol. 170, no. 1-2, doi:10.1016/J.JVIROMET.2010.09.002, ISSN 0166-0934, (20101201), pages 80 - 85, (20101119), XP027507622 [Y] 1-15 * page 82, figure 2(A) *
INTERNATIONAL-SEARCH-REPORT- J. PAN ET AL, "Comparison of the NIDSÂ TM rapid assay with ELISA methods in immunogenicity testing of two biotherapeutics", JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, vol. 63, no. 2, doi:10.1016/J.VASCN.2010.09.003, ISSN 1056-8719, (20100913), pages 150 - 159, (20100922), XP028148453 [AD] 1-15 * figures 3,4 *
INTERNATIONAL-SEARCH-REPORT- B. RUIZ-ARGÜELLO ET AL., "Comparison study of two commercially available methods for thedetermination of infliximab, adalimumab, etanercept and anti-drug antibodylevels.", CLINICAL CHEMISTRY AND LABORATORY MEDICINE, de Gruyter GmbH Berlin, (20131201), vol. 51, no. 12, pages e287 - e289, XP002740685 [A] 1-15 * page e288, column 2, last paragraph *
OPPOSITION- Brendan O'FARRELL, "Chapter 1 - Evolution in Lateral Flow-Based Immunoassay Systems", Brendan O'FARRELL, Raphael Wong, Harley Tse, Lateral Flow Immunoassays, Humana Press, (20090000), pages 1 - 5, ISBN 978-1-58829-908-6, XP055445169-
OPPOSITION- Brown MC, "Chapter 4- Antibodies: Key to a Robust Lateral Flow Immunoassay", Brown MC, Raphael Wong, Harley Tse, Lateral Flow Immunoassays, Humana Press, (20090000), pages 59 - 61, ISBN 978-1-58829-908-6, XP055445180-
OPPOSITION- Theradiag, "LISA-TRACKER Premium Infliximab", Theradiag Product Insert, (20120500), pages 10 - 18, XP055445242-
OPPOSITION- BARTELDS G et al., "Development of Antidrug Antibodies Against Adalimumab and Association With Disease Activity and Treatment Failure During Long- term Follow-up", JAMA, (20110000), vol. 305, no. 14, pages 1460 - 1468, XP055022178
OPPOSITION- PAN J et al., "Comparison of the NIDS ® rapid assay with ELISA methods in immunogenicity testing of two biotherapeutics", JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, (20110000), vol. 63, pages 150 - 159, XP028148453
OPPOSITION- BIAGINI R et al., "Rapid, Sensitive, and Specific Lateral-Flow Immunochroma- tographic Device To Measure Anti-Anthrax Protective Antigen Immunoglobu- lin G in Serum and Whole Blood", CLINICAL AND VACCINE IMMUNOLOGY, (20060500), vol. 13, pages 541 - 546, XP055409712
OPPOSITION- XIANG T et al., "A novel double antibody sandwich-lateral flow immunoassay for the rapid and simple detection of hepatitis C virus", International Journal of Molecular Medicine, (20120000), vol. 30, pages 1041 - 1047, XP055445186

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents